PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Sep-2021 Intrauterine Insemination (IUI) Devices Market is estimated to rise steadily with 3.8% CAGR through 2030 MARKITWIRED
14-Sep-2021 Biognosys Enters Collaboration with Leading Life Science Company to Advance Next-generation Proteomics Businesswire
14-Sep-2021 Microneedle Drug Delivery Systems Market value is poised to reach US$1.2 Bn by the end of 2030 MARKITWIRED
14-Sep-2021 APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and hyperlipidemia APONTIS PHARMA AG
14-Sep-2021 Localized Temperature Therapy Products Market Emerging Demands, Regional Synopsis, Segments Analysis up to 2030 MARKITWIRED
14-Sep-2021 Medical Hyperspectral Imaging Market Top Companies Insights, Development History & Future Growth 2030 MARKITWIRED
14-Sep-2021 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. to Publish its Financial Results for H1 2021 and Operational Progress Vivoryon Therapeutics N.V.
14-Sep-2021 Anatomic Pathology Market is expected to witness a CAGR of over 7.1% by 2030 MARKITWIRED
14-Sep-2021 Poultry Diagnostics Market SWOT Study, Competitive Analysis, Global Industry Research 2030 MARKITWIRED
14-Sep-2021 Smoking Cessation Drugs Market Detail Research, Share, Challenges 2030 MARKITWIRED
14-Sep-2021 The Global Oxytocic Pharmaceuticals Market is expected to reach US$ 207.80 Mn by 2031 MARKITWIRED
14-Sep-2021 Amylase Testing Market Segmentation, Emerging Demands and Global Forecast 2029 MARKITWIRED
14-Sep-2021 Lipid Injectable Market Industry Research, Business Prospects, Regional Outlook 2029 MARKITWIRED
14-Sep-2021 Neurotrophins Market Industry Insights and Global Forecast 2030 MARKITWIRED
14-Sep-2021 Snare devices Market Industry Analysis And Global Outlook 2020-2030 MARKITWIRED
14-Sep-2021 Global Insect cell lines Market Future Challenges and Industry Outlook 2030 MARKITWIRED
14-Sep-2021 Nocturnal Polyuria Treatment Market Industry Analysis And Growth By Top Companies 2030 MARKITWIRED
14-Sep-2021 EQRx Announces Presentation of Updated Data from Pivotal Phase 3 Study of Anti-PD-L1 Antibody Sugemalimab in Combination with Chemotherapy as a First-Line Treatment for Stage IV NSCLC Businesswire
13-Sep-2021 Labcorp Completes Acquisition of Myriad Autoimmune’s Vectra Testing Business Businesswire
13-Sep-2021 IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment Businesswire